FGEN vs NTRS · rev $29.6M vs P/E 18, rev $2.69B
FibroGen Inc (FGEN) versus Northern Trust Corporation (NTRS) — a side-by-side from cached financials, not a winner call.
FibroGen Inc (FGEN) is a biotechnology company listed on NASDAQ.
Northern Trust Corporation (NTRS) is a asset management company listed on US.
Latest reported FGEN revenue for 2024-12-31 was $29.6M. Net income was -$47.6M. Revenue was down 36.7% from 2023-12-31 to 2024-12-31. FGEN currently screens at market cap $39.3M.
Latest reported NTRS revenue for 2026-06-30 was $2.69B. Net income was $1.32B. NTRS currently screens at market cap $32.02B and trailing P/E 18.1.
FGEN currently screens at market cap $39.3M. NTRS currently screens at market cap $32.02B and trailing P/E 18.1.
Not investment advice. Open the FGEN and NTRS stock pages for the full models.
Not investment advice.